60 Degrees Pharmaceuticals
SXTP • NASDAQ
60 Degrees Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Geoffrey Stuart Dow, with a market cap of $4.6M.
Market Cap$4.6M
Employees2.0
CEOGeoffrey Stuart Dow
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 21, 2026 · In 4 weeksBefore Market Open · Q1 2026
Financials
SXT
60 Degrees Pharmaceuticals FAQ
Common questions about 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 21, 2026 before market open. Analysts estimate revenue of $435.0K.
60 Degrees Pharmaceuticals has approximately 2 employees.